Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effectiveness and Safety of Fenfluramine Hydrochloride for Patients with CDKL5 Deficiency Disorder

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Germany Ireland Italy The Netherlands +2
  • Study of Abemaciclib and Temozolomide for Children and Young Adults with Newly Diagnosed High-Grade Glioma After Radiotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium Denmark France Italy The Netherlands Romania +1
  • Study on the Effects of Leniolisib in Children Aged 1 to 6 with Activated PI3K Delta Syndrome (APDS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Portugal Spain
  • Study on the Safety and Effects of Delandistrogene Moxeparvovec in Children Under 4 with Duchenne Muscular Dystrophy

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium France Germany Italy Spain
  • Long-Term Safety Study of Avalglucosidase Alfa for Patients with Pompe Disease in France

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France
  • Study on the Effectiveness and Safety of Regorafenib for Patients with Resistant Primary Bone Tumors

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Poland
  • Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway
  • Study on Preventing Respiratory Issues from RSV Bronchiolitis in Preterm Babies Using Palivizumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Italy
  • Long-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Italy The Netherlands Spain
  • Study on AOC 1001 for Treating Myotonic Dystrophy Type 1 in Patients

    Not recruiting

    3 1
    Denmark France Germany Ireland Italy The Netherlands +1